Florida Funders Managing Partner and "Skin in the Game VC" podcast host Tom Wallace believes that entrepreneurs are game changers and that the companies they envision, create and build make the world a better place. Florida Funders is a venture capital firm and angel network that invests in early stage technology companies. Traditionally, angel investors have not had equal access to the amount of proprietary, vetted deal flow and investment opportunities like a professional venture investor. This podcast was envisioned to educate, connect and activate accredited investors to get skin in the game and invest like a VC.
Hosted on Acast. See acast.com/privacy for more information.
Florida Funders Managing Partner and "Skin in the Game VC" podcast host Tom Wallace believes that entrepreneurs are game changers and that the companies they envision, create and build make the world a better place. Florida Funders is a venture capital firm and angel network that invests in early stage technology companies. Traditionally, angel investors have not had equal access to the amount of proprietary, vetted deal flow and investment opportunities like a professional venture investor. This podcast was envisioned to educate, connect and activate accredited investors to get skin in the game and invest like a VC.
Hosted on Acast. See acast.com/privacy for more information.
In the latest episode of Skin in the Game VC, Tom Wallace and Saxon Baum welcomed Brent Saunders, Chairman and CEO of Bausch & Lomb, to share his journey and insights into leadership, healthcare innovation, and the power of investing in groundbreaking ideas. From his early days as student body president at the University of Pittsburgh to overseeing multi-billion-dollar deals in the healthcare industry, Brent’s career is a masterclass in strategic thinking and execution.
Brent reflected on his experience leading companies like Allergan and Bausch & Lomb, where he navigated complex mergers and acquisitions totaling nearly $300 billion. His approach centers on aligning deals with a strong strategic rationale and financial discipline, ensuring long-term value creation rather than short-term gains.
A recurring theme throughout the conversation was Brent’s passion for leveraging technology to tackle inefficiencies in healthcare. He highlighted the potential of AI to transform drug discovery and streamline clinical trials, sharing how his company uses AI to identify solutions for challenging diseases. Brent also emphasized the need for universal, portable medical records to improve patient outcomes and reduce systemic inefficiencies—a vision that remains elusive but vital for the future.
As an active investor, Brent shared his enthusiasm for backing startups that prioritize innovation and have strong, experienced teams. He cited Roam, a Miami-based tech startup led by Howard Lerman, as an example of a company combining cutting-edge ideas with proven leadership. Brent underscored the value of working with founders who have “climbed the hill before,” noting that their experience and resilience often set them apart.
Looking to the future, Brent offered predictions on market trends, including the growing influence of AI and the expected resurgence in mergers and acquisitions as regulatory conditions evolve. His optimism about technological advancements was balanced by a thoughtful caution regarding overuse in areas like pharmaceuticals, emphasizing the importance of weighing benefits against risks.
The episode was not just a window into Brent’s accomplishments but also a reminder of the power of innovation, the importance of adaptability, and the need to continually refine one’s craft. For anyone navigating the intersection of technology, business, and leadership, Brent’s insights provide both inspiration and actionable guidance.
Be sure to tune in to Skin in the Game VC for more conversations with trailblazing leaders and investors shaping the future.
Hosted on Acast. See acast.com/privacy for more information.